Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera

This publication has 37 references indexed in Scilit:

• HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
  Vaccine, 2011
• Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
  Published by Elsevier ,2010
• Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials
  The Journal of Infectious Diseases, 2009
• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
  Published by Elsevier ,2009
• Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
  JNCI Journal of the National Cancer Institute, 2009
• A review of human carcinogens—Part B: biological agents
  The Lancet Oncology, 2009
• Vaccines: Correlates of Vaccine‐Induced Immunity
  Clinical Infectious Diseases, 2008
• Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
  Vaccine, 2008
• Prevalence of human papillomavirus antibodies in young female subjects in England
  British Journal of Cancer, 2007
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003